Condition
Enoxaparin
Total Trials
3
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 4 (1)
Trial Status
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06357403Recruiting
Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients
NCT03528967Phase 4Completed
Enoxaparin in the Prevention of Placental Insufficiency in Pregnant Women
NCT04402762Phase 1CompletedPrimary
Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®
Showing all 3 trials